Melissa officinalis

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
photo of a white teapot surrounded by green lemon balm leaves and a few halved lemons
Lemon balm herbal tea Source: Pixabay. License: Pixabay open license

Melissa officinalis L., commonly known as lemon balm, is a traditional dietary supplement which has a large number of possible uses.[1][2]

Theory[edit | edit source]

Evidence[edit | edit source]

Clinical trials of melissa officinalis (lemon balm) have not been carried out for patients with ME/CFS. Limited clinical trials exist showing effectiveness for many different symptoms, but these are almost all very small trials, on healthy adults, or provide weak evidence due to being unblinded studies, lack of a control group, or other methodology flaws.[1] Some evidence has been found for lemon balm showing:

Świąder et al. (2019) found most trials used a dose of 300mg or 600mg.[1]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Generally considered safe for adults. Side effects reduced self-rated alertness with the 600mg dose.[1]

Costs and availability[edit | edit source]

Lemon balm extracts, supplements and leafs are widely available and relatively inexpensive.[1]

See also[edit | edit source]

Learn more[edit | edit source]

  • Outside articles: e.g. WebMD, Merck Manual, drugs.com, drugbank.ca, Memorial Sloan Kettering, or ScienceDirect

References[edit | edit source]

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Startek, Katarzyna; Wijaya, Christofora Hanny; Świąder, Katarzyna (2019). "The therapeutic properties of Lemon balm (Melissa officinalis L.): Reviewing novel findings and medical indications". Journal of Applied Botany & Food Quality. 92: 327–335.
  2. 2.0 2.1 Cases, Julien; Ibarra, Alvin; Feuillère, Nicolas; Roller, Marc; Sukkar, Samir G. (2011). "Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances". Mediterranean Journal of Nutrition and Metabolism. 4 (3): 211–218. doi:10.1007/s12349-010-0045-4. ISSN 1973-798X. PMC 3230760. PMID 22207903.